Decreases in transcription factor NRF-1 and coactivator
PGC1 expression contribute to reductions in oxidative gene
expression. (A) Expression of NRF-1 (quantitative PCR), is
decreased in DM (*, P = 0.01 vs. FH- controls). (B)
PGC1α expression (PCR) is reduced in prediabetic FH+ (34%
reduction, P = 0.001 vs. FH-) and DM (36% decrease, P =
0.0009 vs. FH-). (C) PGC1β expression (PCR) is reduced
in prediabetic FH+ (45% reduction, P = 0.045 vs. FH-) and DM (46%
decrease, P = 0.01 vs. FH-).